We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Biochemical Monitoring Devices Measure Analytes in Perspiration

By LabMedica International staff writers
Posted on 25 Mar 2019
Print article
Image: The sensor stimulates sweat under a tiny patch, even when its wearer is cool and resting. The sensor can for a period of hours provide noninvasively the same information found in the blood (Photo courtesy of Joseph Fuqua, University of Cincinnati Creative Services).
Image: The sensor stimulates sweat under a tiny patch, even when its wearer is cool and resting. The sensor can for a period of hours provide noninvasively the same information found in the blood (Photo courtesy of Joseph Fuqua, University of Cincinnati Creative Services).
A recent paper examined the physiology of sweat secretion in order to advance development of peripheral biochemical monitoring devices that test for analytes in perspiration rather than in blood.

Further development of continuous sensing technologies through new electrochemical sensing techniques will be a major focus of future research. While there has been much investment in wearable technologies to sense analytes, less effort has been directed to understanding the physiology of biofluid secretion. Elucidating the underlying biology is crucial for accelerating technological progress, as the biofluid itself often presents the greatest challenge in terms of sample volumes, secretion rates, filtration, active analyte channels, variable pH and salinity, analyte breakdown, and other confounding factors.

Investigators at the University of Cincinnati (OH, USA) had described in the December 21, 2018, online edition of the journal Lab on a Chip a wearable sweat biosensing device that stimulated sweat and continuously measured sweat ethanol concentrations at 25-second intervals. While this work showed that sweat biosensing could provide continuous and blood-correlated data in an integrated wearable device, unresolved questions included operation for 24 hours or greater and with analytes beyond those commonly explored for in sweat (electrolytes and metabolites).

In a more recent study, the investigators described new sensors attached to a wearable patch the size of a Band-Aid that stimulated sweat even when the patient was cool and resting. The sensor measured specific analytes over time so that the data could be used to determine how the patient was responding to a drug treatment.

"For medications, we can use sweat to get an exact measurement of concentrations in the blood," said senior author Dr. Jason Heikenfeld, professor of electrical engineering, materials science and engineering, and biomedical engineering at the University of Cincinnati. "That is important because once we can measure concentrations of therapeutics in blood, we can look at drug dosing. And that could make current dosing look like something from the Stone Age."

The new study was published in the February 25, 2019, online edition of the journal Nature Biotechnology.

Related Links:
University of Cincinnati

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Molecular Diagnostics

view channel
Image: The QIAstat-Dx Analyzer 2.0 with remote test results access enhances collaboration across the healthcare system (Photo courtesy of QIAGEN)

Upgraded Syndromic Testing Analyzer Enables Remote Test Results Access

QIAGEN (Venlo, the Netherlands) has released the QIAstat-Dx Analyzer 2.0, including the Software 1.6 upgrade. This represents a significant advancement from the initial QIAstat-Dx Analyzer 1.... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The RedDrop One blood collection device has received 510(k) clearance from the U.S. FDA for prescription use (Photo courtesy of RedDrop Dx)

Innovative Blood Collection Device Overcomes Common Obstacles Related to Phlebotomy

The discomfort associated with traditional blood draws leads to a significant issue: approximately 30% of diagnostic tests prescribed by physicians are never completed by patients. This avoidance is often... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.